News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
855,010 Results
Type
Article (87031)
Company Profile (704)
Press Release (767263)
Multimedia
Podcasts (154)
Webinars (20)
Section
Business (232897)
Career Advice (4133)
Deals (39769)
Drug Delivery (130)
Drug Development (91144)
Employer Resources (199)
FDA (18214)
Job Trends (17374)
News (396999)
Policy (39850)
Tag
Academia (3002)
Academic (2)
Accelerated approval (15)
Adcomms (33)
Allergies (110)
Alliances (56978)
ALS (123)
Alzheimer's disease (1618)
Antibody-drug conjugate (ADC) (192)
Approvals (18169)
Artificial intelligence (420)
Autoimmune disease (39)
Automation (22)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (139)
Biotechnology (482)
Bladder cancer (105)
Brain cancer (44)
Breast cancer (412)
Cancer (3260)
Cardiovascular disease (261)
Career advice (3542)
Career pathing (34)
CAR-T (217)
CDC (43)
Cell therapy (599)
Cervical cancer (25)
Clinical research (74553)
Collaboration (1168)
Company closure (3)
Compensation (778)
Complete response letters (42)
COVID-19 (2917)
CRISPR (71)
C-suite (405)
Cystic fibrosis (125)
Data (3319)
Decentralized trials (2)
Denatured (55)
Depression (83)
Diabetes (390)
Diagnostics (7009)
Digital health (26)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (195)
Drug pricing (160)
Drug shortages (36)
Duchenne muscular dystrophy (167)
Earnings (98228)
Editorial (50)
Employer branding (25)
Employer resources (169)
Events (131709)
Executive appointments (930)
FDA (20219)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (1049)
Gene editing (154)
Generative AI (42)
Gene therapy (467)
GLP-1 (958)
Government (5297)
Grass and pollen (7)
Guidances (305)
Healthcare (20921)
HIV (47)
Huntington's disease (32)
IgA nephropathy (46)
Immunology and inflammation (197)
Immuno-oncology (15)
Indications (43)
Infectious disease (3124)
Inflammatory bowel disease (168)
Inflation Reduction Act (13)
Influenza (80)
Intellectual property (133)
Interviews (813)
IPO (17908)
IRA (58)
Job creations (5194)
Job search strategy (2863)
Kidney cancer (15)
Labor market (62)
Layoffs (608)
Leadership (27)
Legal (10139)
Liver cancer (87)
Longevity (12)
Lung cancer (453)
Lymphoma (230)
Machine learning (16)
Management (65)
Manufacturing (491)
MASH (106)
Medical device (14765)
Medtech (14775)
Mergers & acquisitions (22630)
Metabolic disorders (995)
Multiple sclerosis (107)
NASH (23)
Neurodegenerative disease (166)
Neuropsychiatric disorders (47)
Neuroscience (2419)
NextGen: Class of 2025 (7687)
Non-profit (5091)
Now hiring (51)
Obesity (504)
Opinion (296)
Ovarian cancer (108)
Pain (132)
Pancreatic cancer (136)
Parkinson's disease (206)
Partnered (25)
Patents (346)
Patient recruitment (198)
Peanut (55)
People (65837)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (22999)
Phase II (32368)
Phase III (24379)
Pipeline (2007)
Policy (260)
Postmarket research (3554)
Preclinical (10389)
Press Release (72)
Prostate cancer (159)
Psychedelics (46)
Radiopharmaceuticals (279)
Rare diseases (551)
Real estate (7402)
Recruiting (76)
Regulatory (27374)
Reports (62)
Research institute (2667)
Resumes & cover letters (650)
Rett syndrome (10)
RNA editing (13)
RSV (62)
Schizophrenia (107)
Series A (175)
Series B (125)
Service/supplier (30)
Sickle cell disease (69)
Special edition (22)
Spinal muscular atrophy (168)
Sponsored (38)
Startups (4309)
State (2)
Stomach cancer (17)
Supply chain (86)
Tariffs (75)
The Weekly (97)
Vaccines (951)
Venture capital (62)
Weight loss (342)
Women's health (53)
Worklife (20)
Date
Today (45)
Last 7 days (804)
Last 30 days (2295)
Last 365 days (33757)
2025 (20549)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (72)
Alaska (7)
Arizona (283)
Arkansas (14)
Asia (50628)
Australia (8895)
California (8241)
Canada (2522)
China (758)
Colorado (352)
Connecticut (367)
Delaware (220)
Europe (116225)
Florida (1229)
Georgia (279)
Hawaii (3)
Idaho (67)
Illinois (763)
India (34)
Indiana (405)
Iowa (19)
Japan (249)
Kansas (118)
Kentucky (34)
Louisiana (20)
Maine (74)
Maryland (1156)
Massachusetts (6286)
Michigan (282)
Minnesota (515)
Mississippi (4)
Missouri (109)
Montana (32)
Nebraska (26)
Nevada (88)
New Hampshire (74)
New Jersey (2293)
New Mexico (31)
New York (2270)
North Carolina (1287)
North Dakota (10)
Northern California (3601)
Ohio (265)
Oklahoma (17)
Oregon (48)
Pennsylvania (1755)
Puerto Rico (18)
Rhode Island (40)
South America (1654)
South Carolina (37)
South Dakota (1)
Southern California (3084)
Tennessee (135)
Texas (1264)
United States (30914)
Utah (241)
Virginia (224)
Washington D.C. (80)
Washington State (716)
West Virginia (4)
Wisconsin (89)
There are 855,010 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Nyxoah Announces Preliminary Results for the Second Quarter of 2025
August 11, 2025
·
7 min read
Press Releases
Idorsia publishes interim results of repurchase offer for its 2025 and 2028 convertible bonds
August 11, 2025
·
5 min read
Press Releases
Relief Therapeutics Advances Publication of 2025 Half-Year Report
August 11, 2025
·
1 min read
Press Releases
Novartis announces both ianalumab Phase III clinical trials met primary endpoint in patients with Sjögren’s disease
August 11, 2025
·
10 min read
Press Releases
Traws Pharma to Report Second Quarter 2025 Financial Results on Thursday, August 14, 2025
August 11, 2025
·
1 min read
Press Releases
Orchestra BioMed Announces Rollout of FDA-Approved BACKBEAT Global Pivotal Study Protocol Update Significantly Expanding Patient Eligibility
August 11, 2025
·
8 min read
Press Releases
Sotera Health Reports Strong Second-Quarter and First-Half 2025 Results
August 11, 2025
·
28 min read
Press Releases
Spectral Medical Announces Second Quarter and Provides Corporate Update
August 11, 2025
·
15 min read
Press Releases
Modular Medical Announces Next-Generation Pivot Insulin Pump at ADCES and Introduction of Level Ex Gamified Training Collaboration
August 11, 2025
·
4 min read
Press Releases
Assembly Biosciences Announces Pricing of $175 Million in Equity Financings
August 11, 2025
·
6 min read
1 of 85,501
Next
